Skip to main content
NCBI home page
Sexually Transmitted Infections logoLink to Sexually Transmitted Infections
. 1998 Feb;74(1):11–19. doi: 10.1136/sti.74.1.11

Influence of ovarian hormones on urogenital infection

C Sonnex
PMCID: PMC1758080  PMID: 9634294

Abstract

Numerous studies have examined the influence of hormones on infectious diseases and there is now a wealth of data relating to the more specific effect of the sex hormones, oestrogen and progesterone, on urogenital infections. The interaction between these hormones and the immune system is complex and the variation of hormonal effect between species further complicates the true picture as related to humans. Although it is difficult therefore to draw general conclusions regarding predominant effects of specific hormones, there is the suggestion that oestrogen enhances the pathogenicity of many urogenital micro-organisms. Our understanding of the influential role played by sex hormones in disease pathogenesis is at an early stage and illustrates well the importance of drawing together and interpreting as a whole both epidemiological and molecular studies. 




Full Text

The Full Text of this article is available as a PDF (123.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ansar Ahmed S., Dauphinée M. J., Montoya A. I., Talal N. Estrogen induces normal murine CD5+ B cells to produce autoantibodies. J Immunol. 1989 Apr 15;142(8):2647–2653. [PubMed] [Google Scholar]
  2. Arbeit J. M., Howley P. M., Hanahan D. Chronic estrogen-induced cervical and vaginal squamous carcinogenesis in human papillomavirus type 16 transgenic mice. Proc Natl Acad Sci U S A. 1996 Apr 2;93(7):2930–2935. doi: 10.1073/pnas.93.7.2930. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Arnold R. R., Cole M. F., McGhee J. R. A bactericidal effect for human lactoferrin. Science. 1977 Jul 15;197(4300):263–265. doi: 10.1126/science.327545. [DOI] [PubMed] [Google Scholar]
  4. Auborn K. J., Woodworth C., DiPaolo J. A., Bradlow H. L. The interaction between HPV infection and estrogen metabolism in cervical carcinogenesis. Int J Cancer. 1991 Dec 2;49(6):867–869. doi: 10.1002/ijc.2910490611. [DOI] [PubMed] [Google Scholar]
  5. Azuma T. A study on the parasiting condition of trichomonas vaginalis with special reference to the relationship between estrogen and the growth of trichomonas vaginalis. J Jpn Obstet Gynecol Soc. 1968 Jul;15(3):168–172. [PubMed] [Google Scholar]
  6. Baker D. A., Phillips C. A., Roessner K., Albertini R. J., Mann L. I. Suppression by progesterone of nonspecific in vitro lymphocyte stimulation in mice as a mechanism for the enhancement of herpes simplex virus type 2 vaginal infection. Am J Obstet Gynecol. 1980 Feb 15;136(4):440–445. doi: 10.1016/0002-9378(80)90668-7. [DOI] [PubMed] [Google Scholar]
  7. Baker D. A., Plotkin S. A. Enhancement of vaginal infection in mice by herpes simplex virus type II with progesterone. Proc Soc Exp Biol Med. 1978 Jun;158(2):131–134. doi: 10.3181/00379727-158-40156. [DOI] [PubMed] [Google Scholar]
  8. Baker D. A., Salvatore W., Milch P. O. Effect of low-dose oral contraceptives on natural killer cell activity. Contraception. 1989 Jan;39(1):119–124. doi: 10.1016/0010-7824(89)90020-6. [DOI] [PubMed] [Google Scholar]
  9. Barron A. L., Pasley J. N., Rank R. G., White H. J., Mrak R. E. Chlamydial salpingitis in female guinea pigs receiving oral contraceptives. Sex Transm Dis. 1988 Jul-Sep;15(3):169–173. doi: 10.1097/00007435-198807000-00013. [DOI] [PubMed] [Google Scholar]
  10. Bartlett J. G., Onderdonk A. B., Drude E., Goldstein C., Anderka M., Alpert S., McCormack W. M. Quantitative bacteriology of the vaginal flora. J Infect Dis. 1977 Aug;136(2):271–277. doi: 10.1093/infdis/136.2.271. [DOI] [PubMed] [Google Scholar]
  11. Bergström H. Estriol in recurrent urinary tract infection in elderly women? Acta Obstet Gynecol Scand Suppl. 1987;140:79–83. doi: 10.3109/00016348709156484. [DOI] [PubMed] [Google Scholar]
  12. Bjercke S., Brandtzaeg P. Glandular distribution of immunoglobulins, J chain, secretory component, and HLA-DR in the human endometrium throughout the menstrual cycle. Hum Reprod. 1993 Sep;8(9):1420–1425. doi: 10.1093/oxfordjournals.humrep.a138271. [DOI] [PubMed] [Google Scholar]
  13. Bodel P., Dillard G. M., Jr, Kaplan S. S., Malawista S. E. Anti-inflammatory effects of estradiol on human blood leukocytes. J Lab Clin Med. 1972 Sep;80(3):373–384. [PubMed] [Google Scholar]
  14. Bose S. K., Goswami P. C. Enhancement of adherence and growth of Chlamydia trachomatis by estrogen treatment of HeLa cells. Infect Immun. 1986 Sep;53(3):646–650. doi: 10.1128/iai.53.3.646-650.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Bradlow H. L., Hershcopf R. J., Martucci C. P., Fishman J. Estradiol 16 alpha-hydroxylation in the mouse correlates with mammary tumor incidence and presence of murine mammary tumor virus: a possible model for the hormonal etiology of breast cancer in humans. Proc Natl Acad Sci U S A. 1985 Sep;82(18):6295–6299. doi: 10.1073/pnas.82.18.6295. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Brandberg A., Mellström D., Samsioe G. Low dose oral estriol treatment in elderly women with urogenital infections. Acta Obstet Gynecol Scand Suppl. 1987;140:33–38. doi: 10.3109/00016348709156476. [DOI] [PubMed] [Google Scholar]
  17. Brick J. E., Wilson D. A., Walker S. E. Hormonal modulation of responses to thymus-independent and thymus-dependent antigens in autoimmune NZB/W mice. J Immunol. 1985 Jun;134(6):3693–3698. [PubMed] [Google Scholar]
  18. Brinton L. A., Huggins G. R., Lehman H. F., Mallin K., Savitz D. A., Trapido E., Rosenthal J., Hoover R. Long-term use of oral contraceptives and risk of invasive cervical cancer. Int J Cancer. 1986 Sep 15;38(3):339–344. doi: 10.1002/ijc.2910380307. [DOI] [PubMed] [Google Scholar]
  19. Brisson J., Morin C., Fortier M., Roy M., Bouchard C., Leclerc J., Christen A., Guimont C., Penault F., Meisels A. Risk factors for cervical intraepithelial neoplasia: differences between low- and high-grade lesions. Am J Epidemiol. 1994 Oct 15;140(8):700–710. doi: 10.1093/oxfordjournals.aje.a117318. [DOI] [PubMed] [Google Scholar]
  20. Britigan B. E., Cohen M. S., Sparling P. F. Gonococcal infection: a model of molecular pathogenesis. N Engl J Med. 1985 Jun 27;312(26):1683–1694. doi: 10.1056/NEJM198506273122606. [DOI] [PubMed] [Google Scholar]
  21. Callewaert D. M., Moudgil V. K., Radcliff G., Waite R. Hormone specific regulation of natural killer cells by cortisol. Direct inactivation of the cytotoxic function of cloned human NK cells without an effect on cellular proliferation. FEBS Lett. 1991 Jul 8;285(1):108–110. doi: 10.1016/0014-5793(91)80736-m. [DOI] [PubMed] [Google Scholar]
  22. Canning M. B., Billington W. D. Hormonal regulation of immunoglobulins and plasma cells in the mouse uterus. J Endocrinol. 1983 Jun;97(3):419–424. doi: 10.1677/joe.0.0970419. [DOI] [PubMed] [Google Scholar]
  23. Cappuccinelli P., Lattes C., Cagliani I., Negro Ponzi A. Features of intravaginal Trichomonas vaginalis infection in the mouse and the effect of oestrogen treatment and immunodepression. G Batteriol Virol Immunol. 1974 Jan-Jun;67(1-6):31–40. [PubMed] [Google Scholar]
  24. Chao T. C., Van Alten P. J., Greager J. A., Walter R. J. Steroid sex hormones regulate the release of tumor necrosis factor by macrophages. Cell Immunol. 1995 Jan;160(1):43–49. doi: 10.1016/0008-8749(95)80007-6. [DOI] [PubMed] [Google Scholar]
  25. Chesnut R. W., Grey H. M. Antigen presenting cells and mechanisms of antigen presentation. Crit Rev Immunol. 1985;5(3):263–316. [PubMed] [Google Scholar]
  26. Ciocca D. R., Puy L. A., Lo Castro G. Localization of an estrogen-responsive protein in the human cervix during menstrual cycle, pregnancy, and menopause and in abnormal cervical epithelia without atypia. Am J Obstet Gynecol. 1986 Nov;155(5):1090–1096. doi: 10.1016/0002-9378(86)90357-1. [DOI] [PubMed] [Google Scholar]
  27. Cohen J. H., Danel L., Cordier G., Saez S., Revillard J. P. Sex steroid receptors in peripheral T cells: absence of androgen receptors and restriction of estrogen receptors to OKT8-positive cells. J Immunol. 1983 Dec;131(6):2767–2771. [PubMed] [Google Scholar]
  28. Cohen M. S., Britigan B. E., French M., Bean K. Preliminary observations on lactoferrin secretion in human vaginal mucus: variation during the menstrual cycle, evidence of hormonal regulation, and implications for infection with Neisseria gonorrhoeae. Am J Obstet Gynecol. 1987 Nov;157(5):1122–1125. doi: 10.1016/s0002-9378(87)80274-0. [DOI] [PubMed] [Google Scholar]
  29. Corriere J. N., Jr, Murphy J. J. The effect of oestrogen upon ascending urinary tract infection in rats. Br J Urol. 1968 Jun;40(3):306–314. doi: 10.1111/j.1464-410x.1968.tb09891.x. [DOI] [PubMed] [Google Scholar]
  30. Cottingham J., Hunter D. Chlamydia trachomatis and oral contraceptive use: a quantitative review. Genitourin Med. 1992 Aug;68(4):209–216. doi: 10.1136/sti.68.4.209. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Cotton D. J., Seligmann B., O'Brien W. F., Gallin J. I. Selective defect in human neutrophil superoxide anion generation elicited by the chemoattractant N-formylmethionylleucylphenylalanine in pregnancy. J Infect Dis. 1983 Aug;148(2):194–199. doi: 10.1093/infdis/148.2.194. [DOI] [PubMed] [Google Scholar]
  32. Crook T., Storey A., Almond N., Osborn K., Crawford L. Human papillomavirus type 16 cooperates with activated ras and fos oncogenes in the hormone-dependent transformation of primary mouse cells. Proc Natl Acad Sci U S A. 1988 Dec;85(23):8820–8824. doi: 10.1073/pnas.85.23.8820. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Crowley T., Horner P., Hughes A., Berry J., Paul I., Caul O. Hormonal factors and the laboratory detection of Chlamydia trachomatis in women: implications for screening? Int J STD AIDS. 1997 Jan;8(1):25–31. doi: 10.1258/0956462971918724. [DOI] [PubMed] [Google Scholar]
  34. Danel L., Souweine G., Monier J. C., Saez S. Specific estrogen binding sites in human lymphoid cells and thymic cells. J Steroid Biochem. 1983 May;18(5):559–563. doi: 10.1016/0022-4731(83)90131-0. [DOI] [PubMed] [Google Scholar]
  35. De M., Sanford T. R., Wood G. W. Interleukin-1, interleukin-6, and tumor necrosis factor alpha are produced in the mouse uterus during the estrous cycle and are induced by estrogen and progesterone. Dev Biol. 1992 May;151(1):297–305. doi: 10.1016/0012-1606(92)90234-8. [DOI] [PubMed] [Google Scholar]
  36. Dennerstein G. J. Depo-Provera in the treatment of recurrent vulvovaginal candidiasis. J Reprod Med. 1986 Sep;31(9):801–803. [PubMed] [Google Scholar]
  37. Dwyer J. M., Knox G. E., Mangi R. J. Cell mediated immunity in healthy women taking oral contraceptives. Yale J Biol Med. 1975 May;48(2):91–95. [PMC free article] [PubMed] [Google Scholar]
  38. Elstein M. Functions and physical properties of mucus in the female genital tract. Br Med Bull. 1978 Jan;34(1):83–88. doi: 10.1093/oxfordjournals.bmb.a071464. [DOI] [PubMed] [Google Scholar]
  39. Eschenbach D. A., Harnisch J. P., Holmes K. K. Pathogenesis of acute pelvic inflammatory disease: role of contraception and other risk factors. Am J Obstet Gynecol. 1977 Aug 15;128(8):838–850. doi: 10.1016/0002-9378(77)90051-5. [DOI] [PubMed] [Google Scholar]
  40. Fenton J., Asselain B., Magdelenat H. Dosage des récepteurs d'oestrogène et de progestérone dans les épithéliomas du col utérin. (A propos d'une série de 101 cas). Bull Cancer. 1986;73(2):124–126. [PubMed] [Google Scholar]
  41. Ferguson M. M., McDonald F. G. Oestrogen as an inhibitor of human NK cell cytolysis. FEBS Lett. 1985 Oct 21;191(1):145–148. doi: 10.1016/0014-5793(85)81011-5. [DOI] [PubMed] [Google Scholar]
  42. Fidel P. L., Jr, Sobel J. D. Immunopathogenesis of recurrent vulvovaginal candidiasis. Clin Microbiol Rev. 1996 Jul;9(3):335–348. doi: 10.1128/cmr.9.3.335. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Flurkey K., Eskinazi D. P., Finch C. E. Estradiol regulates cell surface immunoglobulin in old mice. Dev Comp Immunol. 1986 Winter;10(1):85–91. doi: 10.1016/0145-305x(86)90047-9. [DOI] [PubMed] [Google Scholar]
  44. Ford L. C., Hammill H. A., DeLange R. J., Bruckner D. A., Suzuki-Chavez F., Mickus K. L., Lebherz T. B. Determination of estrogen and androgen receptors in Trichomonas vaginalis and the effects of antihormones. Am J Obstet Gynecol. 1987 May;156(5):1119–1121. doi: 10.1016/0002-9378(87)90122-0. [DOI] [PubMed] [Google Scholar]
  45. Forslin L., Danielsson D., Falk V. Variations in attachment of Neisseria gonorrhoeae to vaginal epithelial cells during the menstrual cycle and early pregnancy. Med Microbiol Immunol. 1979;167(4):231–238. doi: 10.1007/BF02120808. [DOI] [PubMed] [Google Scholar]
  46. Fox H. S., Bond B. L., Parslow T. G. Estrogen regulates the IFN-gamma promoter. J Immunol. 1991 Jun 15;146(12):4362–4367. [PubMed] [Google Scholar]
  47. Furr P. M., Hetherington C. M., Taylor-Robinson D. The susceptibility of germ-free, oestradiol-treated, mice to Mycoplasma hominis. J Med Microbiol. 1989 Nov;30(3):233–236. doi: 10.1099/00222615-30-3-233. [DOI] [PubMed] [Google Scholar]
  48. Furr P. M., Taylor-Robinson D. Enhancement of experimental Mycoplasma pulmonis infection of the mouse genital tract by progesterone treatment. J Hyg (Lond) 1984 Apr;92(2):139–144. doi: 10.1017/s0022172400064147. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Furr P. M., Taylor-Robinson D. Factors influencing the ability of different mycoplasmas to colonize the genital tract of hormone-treated female mice. Int J Exp Pathol. 1993 Feb;74(1):97–101. [PMC free article] [PubMed] [Google Scholar]
  50. Furr P. M., Taylor-Robinson D. Oestradiol-induced infection of the genital tract of female mice by Mycoplasma hominis. J Gen Microbiol. 1989 Oct;135(10):2743–2749. doi: 10.1099/00221287-135-10-2743. [DOI] [PubMed] [Google Scholar]
  51. Furr P. M., Taylor-Robinson D. The contrasting effects of progesterone and oestrogen on the susceptibility of mice to genital infection with Mycoplasma pulmonis. J Med Microbiol. 1993 Mar;38(3):160–165. doi: 10.1099/00222615-38-3-160. [DOI] [PubMed] [Google Scholar]
  52. Furr P. M., Taylor-Robinson D. The establishment and persistence of Ureaplasma urealyticum in oestradiol-treated female mice. J Med Microbiol. 1989 Jun;29(2):111–114. doi: 10.1099/00222615-29-2-111. [DOI] [PubMed] [Google Scholar]
  53. Gabrilovac J., Zadjelović J., Osmak M., Suchanek E., Zupanović Z., Boranić M. NK cell activity and estrogen hormone levels during normal human pregnancy. Gynecol Obstet Invest. 1988;25(3):165–172. doi: 10.1159/000293766. [DOI] [PubMed] [Google Scholar]
  54. Gallichan W. S., Rosenthal K. L. Effects of the estrous cycle on local humoral immune responses and protection of intranasally immunized female mice against herpes simplex virus type 2 infection in the genital tract. Virology. 1996 Oct 15;224(2):487–497. doi: 10.1006/viro.1996.0555. [DOI] [PubMed] [Google Scholar]
  55. Gao Y. L., Twiggs L. B., Leung B. S., Yu W. C., Potish R. A., Okagaki T., Adcock L. L., Prem K. A. Cytoplasmic estrogen and progesterone receptors in primary cervical carcinoma: clinical and histopathologic correlates. Am J Obstet Gynecol. 1983 Jun 1;146(3):299–306. doi: 10.1016/0002-9378(83)90752-4. [DOI] [PubMed] [Google Scholar]
  56. Gibbons R. A. Mucus of the mammalian genital tract. Br Med Bull. 1978 Jan;34(1):34–38. [PubMed] [Google Scholar]
  57. Gloss B., Bernard H. U., Seedorf K., Klock G. The upstream regulatory region of the human papilloma virus-16 contains an E2 protein-independent enhancer which is specific for cervical carcinoma cells and regulated by glucocorticoid hormones. EMBO J. 1987 Dec 1;6(12):3735–3743. doi: 10.1002/j.1460-2075.1987.tb02708.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Gorby G. L., Clemens C. M., Barley L. R., McGee Z. A. Effect of human chorionic gonadotropin (hCG) on Neisseria gonorrhoeae invasion of and IgA secretion by human fallopian tube mucosa. Microb Pathog. 1991 May;10(5):373–384. doi: 10.1016/0882-4010(91)90082-l. [DOI] [PubMed] [Google Scholar]
  59. Gould S. F., Shannon J. M., Cunha G. R. The autoradiographic demonstration of estrogen binding in normal human cervix and vagina during the menstrual cycle, pregnancy, and the menopause. Am J Anat. 1983 Oct;168(2):229–238. doi: 10.1002/aja.1001680209. [DOI] [PubMed] [Google Scholar]
  60. Grossman C. J. Regulation of the immune system by sex steroids. Endocr Rev. 1984 Summer;5(3):435–455. doi: 10.1210/edrv-5-3-435. [DOI] [PubMed] [Google Scholar]
  61. Guinan M. E., MacCalman J., Kern E. R., Overall J. C., Jr, Spruance S. L. The course of untreated recurrent genital herpes simplex infection in 27 women. N Engl J Med. 1981 Mar 26;304(13):759–763. doi: 10.1056/NEJM198103263041305. [DOI] [PubMed] [Google Scholar]
  62. Harle E. M., Bullen J. J., Thomson D. A. Influence of oestrogen on experimental pyelonephritis caused by Escherichia coli. Lancet. 1975 Aug 16;2(7929):283–286. doi: 10.1016/s0140-6736(75)92726-9. [DOI] [PubMed] [Google Scholar]
  63. Harris R. W., Brinton L. A., Cowdell R. H., Skegg D. C., Smith P. G., Vessey M. P., Doll R. Characteristics of women with dysplasia or carcinoma in situ of the cervix uteri. Br J Cancer. 1980 Sep;42(3):359–369. doi: 10.1038/bjc.1980.246. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Head J. R., Gaede S. D. Ia antigen expression in the rat uterus. J Reprod Immunol. 1986 Jul;9(2):137–153. doi: 10.1016/0165-0378(86)90007-0. [DOI] [PubMed] [Google Scholar]
  65. Henry R. J., Goodman J. D., Godley M., Raju K. S., Coffer A. I., King R. J. Immunohistochemical study of cytoplasmic oestradiol receptor in normal, dysplastic and malignant cervical tissue. Br J Obstet Gynaecol. 1988 Sep;95(9):927–932. doi: 10.1111/j.1471-0528.1988.tb06582.x. [DOI] [PubMed] [Google Scholar]
  66. Holmes K. K., Counts G. W., Beaty H. N. Disseminated gonococcal infection. Ann Intern Med. 1971 Jun;74(6):979–993. doi: 10.7326/0003-4819-74-6-979. [DOI] [PubMed] [Google Scholar]
  67. Hooton T. M., Winter C., Tiu F., Stamm W. E. Association of acute cystitis with the stage of the menstrual cycle in young women. Clin Infect Dis. 1996 Sep;23(3):635–636. doi: 10.1093/clinids/23.3.635. [DOI] [PubMed] [Google Scholar]
  68. Hu S. K., Mitcho Y. L., Rath N. C. Effect of estradiol on interleukin 1 synthesis by macrophages. Int J Immunopharmacol. 1988;10(3):247–252. doi: 10.1016/0192-0561(88)90055-0. [DOI] [PubMed] [Google Scholar]
  69. Inman R. D. Immunologic sex differences and the female predominance in systemic lupus erythematosus. Arthritis Rheum. 1978 Sep-Oct;21(7):849–852. doi: 10.1002/art.1780210718. [DOI] [PubMed] [Google Scholar]
  70. Ito J. I., Jr, Harrison H. R., Alexander E. R., Billings L. J. Establishment of genital tract infection in the CF-1 mouse by intravaginal inoculation of a human oculogenital isolate of Chlamydia trachomatis. J Infect Dis. 1984 Oct;150(4):577–582. doi: 10.1093/infdis/150.4.577. [DOI] [PubMed] [Google Scholar]
  71. Iwasaka T., Wada T., Sugimori H. Enhancement of colonization of Ureaplasma urealyticum in the mouse genital tract by estrogen treatment. Am J Obstet Gynecol. 1986 Nov;155(5):1124–1127. doi: 10.1016/0002-9378(86)90363-7. [DOI] [PubMed] [Google Scholar]
  72. Jacobs A. L., Sehgal P. B., Julian J., Carson D. D. Secretion and hormonal regulation of interleukin-6 production by mouse uterine stromal and polarized epithelial cells cultured in vitro. Endocrinology. 1992 Sep;131(3):1037–1046. doi: 10.1210/endo.131.3.1505448. [DOI] [PubMed] [Google Scholar]
  73. Jones C. J., Brinton L. A., Hamman R. F., Stolley P. D., Lehman H. F., Levine R. S., Mallin K. Risk factors for in situ cervical cancer: results from a case-control study. Cancer Res. 1990 Jun 15;50(12):3657–3662. [PubMed] [Google Scholar]
  74. Kalman B., Olsson O., Link H., Kam-Hansen S. Estradiol potentiates poke-weed mitogen-induced B cell stimulation in multiple sclerosis and healthy subjects. Acta Neurol Scand. 1989 Apr;79(4):340–346. doi: 10.1111/j.1600-0404.1989.tb03795.x. [DOI] [PubMed] [Google Scholar]
  75. Kalo-Klein A., Witkin S. S. Regulation of the immune response to Candida albicans by monocytes and progesterone. Am J Obstet Gynecol. 1991 May;164(5 Pt 1):1351–1354. doi: 10.1016/0002-9378(91)90712-z. [DOI] [PubMed] [Google Scholar]
  76. Keith L., Moss W., Berger G. S. Gonorrhea detection in a family planning clinic: a cost-benefit analysis of 2,000 triplicate cultures. Am J Obstet Gynecol. 1975 Feb 1;121(3):399–404. doi: 10.1016/0002-9378(75)90020-4. [DOI] [PubMed] [Google Scholar]
  77. Kinsman O. S., Collard A. E. Hormonal factors in vaginal candidiasis in rats. Infect Immun. 1986 Sep;53(3):498–504. doi: 10.1128/iai.53.3.498-504.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  78. Kinsman O. S., Pitblado K., Coulson C. J. Effect of mammalian steroid hormones and luteinizing hormone on the germination of Candida albicans and implications for vaginal candidosis. Mycoses. 1988 Dec;31(12):617–626. doi: 10.1111/j.1439-0507.1988.tb04416.x. [DOI] [PubMed] [Google Scholar]
  79. Kita E., Takahashi S., Yasui K., Kashiba S. Effect of estrogen (17 beta-estradiol) on the susceptibility of mice to disseminated gonococcal infection. Infect Immun. 1985 Jul;49(1):238–243. doi: 10.1128/iai.49.1.238-243.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  80. Koiter T. R., Hazenberg M. P., van der Schoot P. Regulation of the bacterial microflora of the vagina in cyclic female rats. J Exp Zool. 1977 Oct;202(1):121–128. doi: 10.1002/jez.1402020114. [DOI] [PubMed] [Google Scholar]
  81. Kornman K. S., Loesche W. J. Effects of estradiol and progesterone on Bacteroides melaninogenicus and Bacteroides gingivalis. Infect Immun. 1982 Jan;35(1):256–263. doi: 10.1128/iai.35.1.256-263.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  82. LANG W. R. Vaginal acidity and pH; a review. Obstet Gynecol Surv. 1955 Aug;10(4):546–560. doi: 10.1097/00006254-195508000-00009. [DOI] [PubMed] [Google Scholar]
  83. Larsen B., Galask R. P. Influence of estrogen and normal flora on vaginal candidiasis in the rat. J Reprod Med. 1984 Dec;29(12):863–868. [PubMed] [Google Scholar]
  84. Larsen B., Markovetz A. J., Galask R. P. Quantitative alterations in the genital microflora of female rats in relation to the estrous cycle. J Infect Dis. 1976 Nov;134(5):486–489. doi: 10.1093/infdis/134.5.486. [DOI] [PubMed] [Google Scholar]
  85. Larsen B., Markovetz A. J., Galask R. P. Relationship of vaginal cytology to alterations of the vaginal microflora of rats during the estrous cycle. Appl Environ Microbiol. 1977 Mar;33(3):556–562. doi: 10.1128/aem.33.3.556-562.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  86. Levison M. E., Corman L. C., Carrington E. R., Kaye D. Quantitative microflora of the vagina. Am J Obstet Gynecol. 1977 Jan 1;127(1):80–85. doi: 10.1016/0002-9378(77)90318-0. [DOI] [PubMed] [Google Scholar]
  87. Loose D. S., Feldman D. Characterization of a unique corticosterone-binding protein in Candida albicans. J Biol Chem. 1982 May 10;257(9):4925–4930. [PubMed] [Google Scholar]
  88. Loose D. S., Schurman D. J., Feldman D. A corticosteroid binding protein and endogenous ligand in C. albicans indicating a possible steroid-receptor system. Nature. 1981 Oct 8;293(5832):477–479. doi: 10.1038/293477a0. [DOI] [PubMed] [Google Scholar]
  89. Louv W. C., Austin H., Perlman J., Alexander W. J. Oral contraceptive use and the risk of chlamydial and gonococcal infections. Am J Obstet Gynecol. 1989 Feb;160(2):396–402. doi: 10.1016/0002-9378(89)90456-0. [DOI] [PubMed] [Google Scholar]
  90. Madani N. D., Malloy P. J., Rodriguez-Pombo P., Krishnan A. V., Feldman D. Candida albicans estrogen-binding protein gene encodes an oxidoreductase that is inhibited by estradiol. Proc Natl Acad Sci U S A. 1994 Feb 1;91(3):922–926. doi: 10.1073/pnas.91.3.922. [DOI] [PMC free article] [PubMed] [Google Scholar]
  91. Mahmoud E. A., Hamad E. E., Olsson S. E., Mårdh P. A. Antichlamydial activity of cervical secretion in different phases of the menstrual cycle and influence of hormonal contraceptives. Contraception. 1994 Mar;49(3):265–274. doi: 10.1016/0010-7824(94)90044-2. [DOI] [PubMed] [Google Scholar]
  92. Malaise M. G., Franchimont P., Mahieu P. R. Evidence that the phagocytosis mediated by the peanut agglutinin-like activity of IgG(Fc) receptors of human monocytes is selectively modulated by estradiol and natural estrogens. J Clin Immunol. 1988 Nov;8(6):495–502. doi: 10.1007/BF00916956. [DOI] [PubMed] [Google Scholar]
  93. Mandeville R., Sombo F. M., Rocheleau N. Natural cell-mediated cytotoxicity in normal human peripheral blood lymphocytes and its in vitro boosting with BCG. Cancer Immunol Immunother. 1983;15(1):17–22. doi: 10.1007/BF00199456. [DOI] [PMC free article] [PubMed] [Google Scholar]
  94. Maslow A. S., Davis C. H., Choong J., Wyrick P. B. Estrogen enhances attachment of Chlamydia trachomatis to human endometrial epithelial cells in vitro. Am J Obstet Gynecol. 1988 Oct;159(4):1006–1014. doi: 10.1016/s0002-9378(88)80189-3. [DOI] [PubMed] [Google Scholar]
  95. McDermott M. R., Clark D. A., Bienenstock J. Evidence for a common mucosal immunologic system. II. Influence of the estrous cycle on B immunoblast migration into genital and intestinal tissues. J Immunol. 1980 Jun;124(6):2536–2539. [PubMed] [Google Scholar]
  96. Mindel A., Coker D. M., Faherty A., Williams P. Recurrent genital herpes: clinical and virological features in men and women. Genitourin Med. 1988 Apr;64(2):103–106. doi: 10.1136/sti.64.2.103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  97. Mitrani-Rosenbaum S., Tsvieli R., Tur-Kaspa R. Oestrogen stimulates differential transcription of human papillomavirus type 16 in SiHa cervical carcinoma cells. J Gen Virol. 1989 Aug;70(Pt 8):2227–2232. doi: 10.1099/0022-1317-70-8-2227. [DOI] [PubMed] [Google Scholar]
  98. Mizoguchi Y., Ikemoto Y., Yamamoto S., Morisawa S. Studies on the effects of estrogen on the antibody response in asymptomatic HB virus carrier. Hepatogastroenterology. 1985 Jun;32(3):109–112. [PubMed] [Google Scholar]
  99. Molander U., Milsom I., Ekelund P., Mellström D., Eriksson O. Effect of oral oestriol on vaginal flora and cytology and urogenital symptoms in the post-menopause. Maturitas. 1990 Jun;12(2):113–120. doi: 10.1016/0378-5122(90)90089-o. [DOI] [PubMed] [Google Scholar]
  100. Monsonego J., Magdelenat H., Catalan F., Coscas Y., Zerat L., Sastre X. Estrogen and progesterone receptors in cervical human papillomavirus related lesions. Int J Cancer. 1991 Jun 19;48(4):533–539. doi: 10.1002/ijc.2910480410. [DOI] [PubMed] [Google Scholar]
  101. Mori H., Sawairi M., Itoh N., Hanabayashi T., Tamaya T. Effects of sex steroids on immunoglobulin M production by Epstein-Barr virus-transformed B-cell line SKW6-CL4. J In Vitro Fert Embryo Transf. 1991 Dec;8(6):329–335. doi: 10.1007/BF01133023. [DOI] [PubMed] [Google Scholar]
  102. Mulholland S. G., Qureshi S. M., Fritz R. W., Silverman H. Effect of hormonal deprivation on the bladder defense mechanism. J Urol. 1982 May;127(5):1010–1013. doi: 10.1016/s0022-5347(17)54176-2. [DOI] [PubMed] [Google Scholar]
  103. Murr S. M., Stabenfeldt G. H., Bradford G. E., Geschwind I. I. Plasma progesterone during pregnancy in the mouse. Endocrinology. 1974 Apr;94(4):1209–1211. doi: 10.1210/endo-94-4-1209. [DOI] [PubMed] [Google Scholar]
  104. Myers M. J., Petersen B. H. Estradiol induced alterations of the immune system--I. Enhancement of IgM production. Int J Immunopharmacol. 1985;7(2):207–213. doi: 10.1016/0192-0561(85)90028-1. [DOI] [PubMed] [Google Scholar]
  105. Mårdh P. A., Soltész L. V. In vitro interactions between lactobacilli and other microorganisms occurring in the vaginal flora. Scand J Infect Dis Suppl. 1983;40:47–51. [PubMed] [Google Scholar]
  106. Mårdh P. A., Westtöm L. Adherence of bacterial to vaginal epithelial cells. Infect Immun. 1976 Mar;13(3):661–666. doi: 10.1128/iai.13.3.661-666.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  107. Nahmias A. J., Josey W. E., Naib Z. M., Freeman M. G., Fernandez R. J., Wheeler J. H. Perinatal risk associated with maternal genital herpes simplex virus infection. Am J Obstet Gynecol. 1971 Jul 15;110(6):825–837. doi: 10.1016/0002-9378(71)90580-1. [DOI] [PubMed] [Google Scholar]
  108. Neary M. P., Allen J., Okubadejo O. A., Payne D. J. Preoperative vaginal bacteria and postoperative infections in gynaecological patients. Lancet. 1973 Dec 8;2(7841):1291–1294. doi: 10.1016/s0140-6736(73)92870-5. [DOI] [PubMed] [Google Scholar]
  109. Negrini B. P., Schiffman M. H., Kurman R. J., Barnes W., Lannom L., Malley K., Brinton L. A., Delgado G., Jones S., Tchabo J. G. Oral contraceptive use, human papillomavirus infection, and risk of early cytological abnormalities of the cervix. Cancer Res. 1990 Aug 1;50(15):4670–4675. [PubMed] [Google Scholar]
  110. Ness R. B., Keder L. M., Soper D. E., Amortegui A. J., Gluck J., Wiesenfeld H., Sweet R. L., Rice P. A., Peipert J. F., Donegan S. P. Oral contraception and the recognition of endometritis. Am J Obstet Gynecol. 1997 Mar;176(3):580–585. doi: 10.1016/s0002-9378(97)70551-9. [DOI] [PubMed] [Google Scholar]
  111. Ng A. B., Reagan J. W., Yen S. S. Hepres genitalis; clinical and cytopathologic experience with 256 patients. Obstet Gynecol. 1970 Oct;36(4):645–651. [PubMed] [Google Scholar]
  112. Nilsson B., Carlsson S., Damber M. G., Lindblom D., Södergård R., von Schoultz B. Specific binding of 17 beta-estradiol in the human thymus. Am J Obstet Gynecol. 1984 Jul 1;149(5):544–547. doi: 10.1016/0002-9378(84)90033-4. [DOI] [PubMed] [Google Scholar]
  113. Nilsson B., Damber M. G., von Schoultz B. Effect of estrogen/progestogen combinations on polymorphonuclear leucocyte chemotaxis. Acta Obstet Gynecol Scand. 1980;59(2):165–168. doi: 10.3109/00016348009154635. [DOI] [PubMed] [Google Scholar]
  114. Nishikawa Y., Baba T. Effects of ovarian hormones on manifestation of purulent endometritis in rat uteruses infected with Escherichia coli. Infect Immun. 1985 Jan;47(1):311–317. doi: 10.1128/iai.47.1.311-317.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  115. Nishikawa Y., Baba T., Imori T. Effect of the estrous cycle on uterine infection induced by Escherichia coli. Infect Immun. 1984 Feb;43(2):678–683. doi: 10.1128/iai.43.2.678-683.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  116. Nishikawa Y., Baba T. In vitro adherence of Escherichia coli to endometrial epithelial cells of rats and influence of estradiol. Infect Immun. 1985 Nov;50(2):506–509. doi: 10.1128/iai.50.2.506-509.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  117. Nohmi T., Abe S., Dobashi K., Tansho S., Yamaguchi H. Suppression of anti-Candida activity of murine neutrophils by progesterone in vitro: a possible mechanism in pregnant women's vulnerability to vaginal candidiasis. Microbiol Immunol. 1995;39(6):405–409. doi: 10.1111/j.1348-0421.1995.tb02220.x. [DOI] [PubMed] [Google Scholar]
  118. Oram J. D., Reiter B. Inhibition of bacteria by lactoferrin and other iron-chelating agents. Biochim Biophys Acta. 1968 Dec 23;170(2):351–365. doi: 10.1016/0304-4165(68)90015-9. [DOI] [PubMed] [Google Scholar]
  119. Overall J. C., Jr, Kern E. R., Schlitzer R. L., Friedman S. B., Glasgow L. A. Genital herpesvirus hominis infection in mice. I. Development of an experimental model. Infect Immun. 1975 Mar;11(3):476–480. doi: 10.1128/iai.11.3.476-480.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  120. Paavonen T., Andersson L. C., Adlercreutz H. Sex hormone regulation of in vitro immune response. Estradiol enhances human B cell maturation via inhibition of suppressor T cells in pokeweed mitogen-stimulated cultures. J Exp Med. 1981 Dec 1;154(6):1935–1945. doi: 10.1084/jem.154.6.1935. [DOI] [PMC free article] [PubMed] [Google Scholar]
  121. Parsons C. L., Schmidt J. D. Control of recurrent lower urinary tract infection in the postmenopausal woman. J Urol. 1982 Dec;128(6):1224–1226. doi: 10.1016/s0022-5347(17)53434-5. [DOI] [PubMed] [Google Scholar]
  122. Pasley J. N., Rank R. G., Hough A. J., Jr, Cohen C., Barron A. L. Absence of progesterone effects on chlamydial genital infection in female guinea pigs. Sex Transm Dis. 1985 Jul-Sep;12(3):155–158. doi: 10.1097/00007435-198507000-00012. [DOI] [PubMed] [Google Scholar]
  123. Pater A., Bayatpour M., Pater M. M. Oncogenic transformation by human papillomavirus type 16 deoxyribonucleic acid in the presence of progesterone or progestins from oral contraceptives. Am J Obstet Gynecol. 1990 Apr;162(4):1099–1103. doi: 10.1016/0002-9378(90)91323-5. [DOI] [PubMed] [Google Scholar]
  124. Pater M. M., Mittal R., Pater A. Role of steroid hormones in potentiating transformation of cervical cells by human papillomaviruses. Trends Microbiol. 1994 Jul;2(7):229–234. doi: 10.1016/0966-842x(94)90627-0. [DOI] [PubMed] [Google Scholar]
  125. Patton D. L., Sweeney Y. T., Kuo C. C. Oral contraceptives do not alter the course of experimentally induced chlamydial salpingitis in monkeys. Sex Transm Dis. 1994 Mar-Apr;21(2):89–92. doi: 10.1097/00007435-199403000-00006. [DOI] [PubMed] [Google Scholar]
  126. Pfeifer R. W., Patterson R. M. Modulation of lectin-stimulated lymphocyte agglutination and mitogenesis by estrogen metabolites: effects on early events of lymphocyte activation. Arch Toxicol. 1986 Feb;58(3):157–164. doi: 10.1007/BF00340975. [DOI] [PubMed] [Google Scholar]
  127. Pol'shin V. V., Shelegiia G. Sh, Mkhitarov V. A. Vliianie follikulina i éstradiol-dipropionate na fagotsitarnye svoistva neitrofilov krovi u samok belykh krys. Fiziol Zh SSSR Im I M Sechenova. 1986 Feb;72(2):221–223. [PubMed] [Google Scholar]
  128. Polan M. L., Daniele A., Kuo A. Gonadal steroids modulate human monocyte interleukin-1 (IL-1) activity. Fertil Steril. 1988 Jun;49(6):964–968. [PubMed] [Google Scholar]
  129. Pottratz S. T., Bellido T., Mocharla H., Crabb D., Manolagas S. C. 17 beta-Estradiol inhibits expression of human interleukin-6 promoter-reporter constructs by a receptor-dependent mechanism. J Clin Invest. 1994 Mar;93(3):944–950. doi: 10.1172/JCI117100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  130. Prabhala R. H., Wira C. R. Sex hormone and IL-6 regulation of antigen presentation in the female reproductive tract mucosal tissues. J Immunol. 1995 Dec 15;155(12):5566–5573. [PubMed] [Google Scholar]
  131. Quarmby V. E., Korach K. S. The influence of 17 beta-estradiol on patterns of cell division in the uterus. Endocrinology. 1984 Mar;114(3):694–702. doi: 10.1210/endo-114-3-694. [DOI] [PubMed] [Google Scholar]
  132. Rachman F., Casimiri V., Psychoyos A., Bernard O. Immunoglobulins in the mouse uterus during the oestrous cycle. J Reprod Fertil. 1983 Sep;69(1):17–21. doi: 10.1530/jrf.0.0690017. [DOI] [PubMed] [Google Scholar]
  133. Rank R. G., Sanders M. M., Kidd A. T. Influence of the estrous cycle on the development of upper genital tract pathology as a result of chlamydial infection in the guinea pig model of pelvic inflammatory disease. Am J Pathol. 1993 Apr;142(4):1291–1296. [PMC free article] [PubMed] [Google Scholar]
  134. Raz R., Stamm W. E. A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections. N Engl J Med. 1993 Sep 9;329(11):753–756. doi: 10.1056/NEJM199309093291102. [DOI] [PubMed] [Google Scholar]
  135. Reeves W. C., Corey L., Adams H. G., Vontver L. A., Holmes K. K. Risk of recurrence after first episodes of genital herpes. Relation to HSV type and antibody response. N Engl J Med. 1981 Aug 6;305(6):315–319. doi: 10.1056/NEJM198108063050604. [DOI] [PubMed] [Google Scholar]
  136. Riedasch G., Setzis K., Bersch W., Ritz E. Estrogens influence antibody coating in experimental urinary tract infection. Klin Wochenschr. 1983 May 16;61(10):529–531. doi: 10.1007/BF01488721. [DOI] [PubMed] [Google Scholar]
  137. Roth J. A., Kaeberle M. L., Appell L. H., Nachreiner R. F. Association of increased estradiol and progesterone blood values with altered bovine polymorphonuclear leukocyte function. Am J Vet Res. 1983 Feb;44(2):247–253. [PubMed] [Google Scholar]
  138. Sautter R. L., Brown W. J. Sequential vaginal cultures from normal young women. J Clin Microbiol. 1980 May;11(5):479–484. doi: 10.1128/jcm.11.5.479-484.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  139. Schaeffer A. J., Amundsen S. K., Schmidt L. N. Adherence of Escherichia coli to human urinary tract epithelial cells. Infect Immun. 1979 Jun;24(3):753–759. doi: 10.1128/iai.24.3.753-759.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  140. Schneider A., Hotz M., Gissmann L. Increased prevalence of human papillomaviruses in the lower genital tract of pregnant women. Int J Cancer. 1987 Aug 15;40(2):198–201. doi: 10.1002/ijc.2910400212. [DOI] [PubMed] [Google Scholar]
  141. Screpanti I., Santoni A., Gulino A., Herberman R. B., Frati L. Estrogen and antiestrogen modulation of the levels of mouse natural killer activity and large granular lymphocytes. Cell Immunol. 1987 May;106(2):191–202. doi: 10.1016/0008-8749(87)90163-8. [DOI] [PubMed] [Google Scholar]
  142. Seaman W. E., Blackman M. A., Gindhart T. D., Roubinian J. R., Loeb J. M., Talal N. beta-Estradiol reduces natural killer cells in mice. J Immunol. 1978 Dec;121(6):2193–2198. [PubMed] [Google Scholar]
  143. Sharma S., Madhur B. S., Singh R., Sharma B. K. Effect of contraceptives on the adhesion of Escherichia coli to uroepithelial cells. J Infect Dis. 1987 Sep;156(3):490–494. [PubMed] [Google Scholar]
  144. Sivam G., Cohen M. S., Dodd R. C., Gray T. K. 17 Beta-estradiol inhibits the oxidative metabolism of U937 cells indirectly via lymphocytes. Endocrinology. 1987 Sep;121(3):853–857. doi: 10.1210/endo-121-3-853. [DOI] [PubMed] [Google Scholar]
  145. Skowronski R., Feldman D. Characterization of an estrogen-binding protein in the yeast Candida albicans. Endocrinology. 1989 Apr;124(4):1965–1972. doi: 10.1210/endo-124-4-1965. [DOI] [PubMed] [Google Scholar]
  146. Sobel J. D., Kaye D. Enhancement of Escherichia coli adherence to epithelial cells derived from estrogen-stimulated rats. Infect Immun. 1986 Jul;53(1):53–56. doi: 10.1128/iai.53.1.53-56.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  147. Sobel J. D., Schneider J., Kaye D., Levison M. E. Adherence of bacteria to vaginal epithelial cells at various times in the menstrual cycle. Infect Immun. 1981 Apr;32(1):194–197. doi: 10.1128/iai.32.1.194-197.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  148. Sonnex C. Recurrent genital tract infection: a result of induced immunosuppression? Genitourin Med. 1989 Dec;65(6):372–375. doi: 10.1136/sti.65.6.372. [DOI] [PMC free article] [PubMed] [Google Scholar]
  149. Stamey T. A., Sexton C. C. The role of vaginal colonization with enterobacteriaceae in recurrent urinary infections. J Urol. 1975 Feb;113(2):214–217. doi: 10.1016/s0022-5347(17)59447-1. [DOI] [PubMed] [Google Scholar]
  150. Sthoeger Z. M., Chiorazzi N., Lahita R. G. Regulation of the immune response by sex hormones. I. In vitro effects of estradiol and testosterone on pokeweed mitogen-induced human B cell differentiation. J Immunol. 1988 Jul 1;141(1):91–98. [PubMed] [Google Scholar]
  151. Stimson W. H., Hunter I. C. Oestrogen-induced immunoregulation mediated through the thymus. J Clin Lab Immunol. 1980 Jul;4(1):27–33. [PubMed] [Google Scholar]
  152. Stimson W. H. Oestrogen and human T lymphocytes: presence of specific receptors in the T-suppressor/cytotoxic subset. Scand J Immunol. 1988 Sep;28(3):345–350. doi: 10.1111/j.1365-3083.1988.tb01459.x. [DOI] [PubMed] [Google Scholar]
  153. Sugarman B., Agbor P. Estrogens and Chlamydia trachomatis. Proc Soc Exp Biol Med. 1986 Oct;183(1):125–131. doi: 10.3181/00379727-183-42396. [DOI] [PubMed] [Google Scholar]
  154. Sugarman B., Mummaw N. Effects of antimicrobial agents on growth and chemotaxis of Trichomonas vaginalis. Antimicrob Agents Chemother. 1988 Sep;32(9):1323–1326. doi: 10.1128/aac.32.9.1323. [DOI] [PMC free article] [PubMed] [Google Scholar]
  155. Sugarman B., Mummaw N. Oestrogen binding by and effect of oestrogen on trichomonads and bacteria. J Med Microbiol. 1990 Aug;32(4):227–232. doi: 10.1099/00222615-32-4-227. [DOI] [PubMed] [Google Scholar]
  156. Sugarman B., Mummaw N. The effect of hormones on Trichomonas vaginalis. J Gen Microbiol. 1988 Jun;134(6):1623–1628. doi: 10.1099/00221287-134-6-1623. [DOI] [PubMed] [Google Scholar]
  157. Sullivan D. A., Richardson G. S., MacLaughlin D. T., Wira C. R. Variations in the levels of secretory component in human uterine fluid during the menstrual cycle. J Steroid Biochem. 1984 Jan;20(1):509–513. doi: 10.1016/0022-4731(84)90263-2. [DOI] [PubMed] [Google Scholar]
  158. Sullivan D. A., Underdown B. J., Wira C. R. Steroid hormone regulation of free secretory component in the rat uterus. Immunology. 1983 Jun;49(2):379–386. [PMC free article] [PubMed] [Google Scholar]
  159. Sweet R. L., Blankfort-Doyle M., Robbie M. O., Schacter J. The occurrence of chlamydial and gonococcal salpingitis during the menstrual cycle. JAMA. 1986 Apr 18;255(15):2062–2064. [PubMed] [Google Scholar]
  160. Tabibzadeh S. S., Santhanam U., Sehgal P. B., May L. T. Cytokine-induced production of IFN-beta 2/IL-6 by freshly explanted human endometrial stromal cells. Modulation by estradiol-17 beta. J Immunol. 1989 May 1;142(9):3134–3139. [PubMed] [Google Scholar]
  161. Tabibzadeh S. Evidence of T-cell activation and potential cytokine action in human endometrium. J Clin Endocrinol Metab. 1990 Sep;71(3):645–649. doi: 10.1210/jcem-71-3-645. [DOI] [PubMed] [Google Scholar]
  162. Taylor-Robinson D., Furr P. M. Elimination of mycoplasmas from the murine genital tract by hormone treatment. Epidemiol Infect. 1990 Aug;105(1):163–168. doi: 10.1017/s0950268800047749. [DOI] [PMC free article] [PubMed] [Google Scholar]
  163. Taylor-Robinson D., Furr P. M., Hetherington C. M. Neisseria gonorrhoeae colonises the genital tract of oestradiol-treated germ-free female mice. Microb Pathog. 1990 Nov;9(5):369–373. doi: 10.1016/0882-4010(90)90071-w. [DOI] [PubMed] [Google Scholar]
  164. Teepe A. G., Allen L. B., Wordinger R. J., Harris E. F. Effect of the estrous cycle on susceptibility of female mice to intravaginal inoculation of herpes simplex virus type 2 (HSV-2). Antiviral Res. 1990 Oct-Nov;14(4-5):227–235. doi: 10.1016/0166-3542(90)90004-q. [DOI] [PubMed] [Google Scholar]
  165. Trinchieri G., Perussia B. Human natural killer cells: biologic and pathologic aspects. Lab Invest. 1984 May;50(5):489–513. [PubMed] [Google Scholar]
  166. Tubiana N., Derre M., Carcassonne Y., Martin P. M. Sex steroid binding to human lymphocytes plasma membrane. Br J Cancer. 1984 Apr;49(4):531–535. doi: 10.1038/bjc.1984.81. [DOI] [PMC free article] [PubMed] [Google Scholar]
  167. Tubiana N., Mishal Z., le Caer F., Seigneurin J. M., Berthoix Y., Martin P. M., Carcassonne Y. Quantification of oestradiol binding at the surface of human lymphocytes by flow cytofluorimetry. Br J Cancer. 1986 Sep;54(3):501–504. doi: 10.1038/bjc.1986.203. [DOI] [PMC free article] [PubMed] [Google Scholar]
  168. Tuffrey M., Falder P., Taylor-Robinson D. Genital-tract infection and disease in nude and immunologically competent mice after inoculation of a human strain of Chlamydia trachomatis. Br J Exp Pathol. 1982 Oct;63(5):539–546. [PMC free article] [PubMed] [Google Scholar]
  169. Usala S. J., Usala F. O., Haciski R., Holt J. A., Schumacher G. F. IgG and IgA content of vaginal fluid during the menstrual cycle. J Reprod Med. 1989 Apr;34(4):292–294. [PubMed] [Google Scholar]
  170. Venegas M. F., Navas E. L., Gaffney R. A., Duncan J. L., Anderson B. E., Schaeffer A. J. Binding of type 1-piliated Escherichia coli to vaginal mucus. Infect Immun. 1995 Feb;63(2):416–422. doi: 10.1128/iai.63.2.416-422.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  171. Vessey M. P., Lawless M., McPherson K., Yeates D. Neoplasia of the cervix uteri and contraception: a possible adverse effect of the pill. Lancet. 1983 Oct 22;2(8356):930–934. doi: 10.1016/s0140-6736(83)90451-8. [DOI] [PubMed] [Google Scholar]
  172. Washington A. E., Gove S., Schachter J., Sweet R. L. Oral contraceptives, Chlamydia trachomatis infection, and pelvic inflammatory disease. A word of caution about protection. JAMA. 1985 Apr 19;253(15):2246–2250. [PubMed] [Google Scholar]
  173. Weinberger O., Herrmann S., Mescher M. F., Benacerraf B., Burakoff S. J. Antigen-presenting cell function in induction of helper T cells for cytotoxic T-lymphocyte responses: evidence for antigen processing. Proc Natl Acad Sci U S A. 1981 Mar;78(3):1796–1799. doi: 10.1073/pnas.78.3.1796. [DOI] [PMC free article] [PubMed] [Google Scholar]
  174. Weusten J. J., Blankenstein M. A., Gmelig-Meyling F. H., Schuurman H. J., Kater L., Thijssen J. H. Presence of oestrogen receptors in human blood mononuclear cells and thymocytes. Acta Endocrinol (Copenh) 1986 Jul;112(3):409–414. doi: 10.1530/acta.0.1120409. [DOI] [PubMed] [Google Scholar]
  175. White D. J., Johnson E. M., Warnock D. W. Management of persistent vulvo vaginal candidosis due to azole-resistant Candida glabrata. Genitourin Med. 1993 Apr;69(2):112–114. doi: 10.1136/sti.69.2.112. [DOI] [PMC free article] [PubMed] [Google Scholar]
  176. Wira C. R., Rossoll R. M. Antigen-presenting cells in the female reproductive tract: influence of sex hormones on antigen presentation in the vagina. Immunology. 1995 Apr;84(4):505–508. [PMC free article] [PubMed] [Google Scholar]
  177. Wira C. R., Sandoe C. P. Sex steroid hormone regulation of IgA and IgG in rat uterine secretions. Nature. 1977 Aug 11;268(5620):534–536. doi: 10.1038/268534a0. [DOI] [PubMed] [Google Scholar]
  178. Wira C. R., Sullivan D. A. Estradiol and progesterone regulation of immunoglobulin A and G and secretory component in cervicovaginal secretions of the rat. Biol Reprod. 1985 Feb;32(1):90–95. doi: 10.1095/biolreprod32.1.90. [DOI] [PubMed] [Google Scholar]
  179. Wølner-Hanssen P., Eschenbach D. A., Paavonen J., Kiviat N., Stevens C. E., Critchlow C., DeRouen T., Holmes K. K. Decreased risk of symptomatic chlamydial pelvic inflammatory disease associated with oral contraceptive use. JAMA. 1990 Jan 5;263(1):54–59. doi: 10.1001/jama.1990.03440010052029. [DOI] [PubMed] [Google Scholar]
  180. el-Boulaqi H. A., el-Refaie S. A., Bassiouny G. A., Amin F. M. The relation between Trichomonas vaginalis and contraceptive measures. J Egypt Soc Parasitol. 1984 Dec;14(2):495–499. [PubMed] [Google Scholar]

Articles from Sexually Transmitted Infections are provided here courtesy of BMJ Publishing Group

RESOURCES